课题基金 / 基金详情

项目摘要

项目成果

Deborah J Anderson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions): This Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM) brings together a network of investigators representing two companies and five academic institutions to perform multidisciplinary preclinical and exploratory clinical studies with the goal of advancing a safe, novel trivalent topical microbicide, mapp66. This microbicide formulation is comprised of three monoclonal antibodies (Mabs), produced by genetic engineering in Nicotiana benthamiana (-N), that are designed to block distinct mechanisms of HIV sexual transmission. Success of this IPCP-HTM will rely upon an Administrative Core (Core A) that will provide scientific and administrative leadership in coordinating the six Scientific Projects, and the multiple sites that make up this IPCP-HTM program. The Administrative Core will also coordinate data and materials acquisition and sharing so that the research progresses in an integrated iterative fashion to meet individual project and programmatic milestones. The Specific Aims of the Administrative Core are: 1. To provide scientific leadership and administrative oversight. Specifically, Core A will establish an Executive Committee (EC) for ongoing assessment of project and core milestones, resource allocation and changes to the experimental design. Core A will also convene a Scientific Advisory Panel (SAP) to review the program in years 3 and 5. Core A will facilitate communication through scheduled conference calls and investigator meetings, provide financial and administrative support, and insure adherence to institutional and federal guidelines 2. To coordinate data and materials acquisition and sharing to insure that project and program milestones are met. Specifically, Core A will be responsible for the reagent/research material and data management and sharing plan, for monitoring milestone achievements and coordinating biostatistical services, if required by the individual projects/cores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthetic mRNA-mediated reversible immunocontraception
  • 批准号:
    10018523
  • 项目类别:
  • 资助金额:
    $38.05万
  • 财政年份:
    2019
  • 负责人:
    Deborah J Anderson
  • 依托单位:
Synthetic mRNA-mediated reversible immunocontraception
  • 批准号:
    10474919
  • 项目类别:
  • 资助金额:
    $68.75万
  • 财政年份:
    2019
  • 负责人:
    Deborah J Anderson
  • 依托单位:
Administrative Core
  • 批准号:
    10159118
  • 项目类别:
  • 资助金额:
    $51.52万
  • 财政年份:
    2018
  • 负责人:
    Deborah J Anderson
  • 依托单位:
Core A: Administration
  • 批准号:
    10532091
  • 项目类别:
  • 资助金额:
    $21.26万
  • 财政年份:
    2018
  • 负责人:
    Deborah J Anderson
  • 依托单位:
海外基金